Ergoteles’s Hims & Hers Health HIMS Stock Holding History

Ergoteles’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-178,000	Closed	-$949K	–	1795
2022 Q1	$949K	Buy	+178,000	New	+$880K	0.04%	443

Other funds holding HIMS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return

Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return

Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return

Forerunner Ventures Management San Francisco, California $169M AUM

NewView HMS SPV Partners Burlingame, California $53.9M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Ergoteles's HIMS Position: Q2 2022 in Review

Ergoteles sold out of Hims & Hers Health (HIMS) in Q2 2022, closing a stake of 178,000 shares — an estimated $949K sold.

Ergoteles first reported a position in HIMS in Q1 2022 and held it in 1 quarter. The position peaked at $949K in Q1 2022. 139 funds tracked by Wall St. Rank hold HIMS as of Q2 2022.

Ergoteles reported no remaining Hims & Hers Health position as of Q2 2022 after selling out during the quarter.
Ergoteles sold 178,000 Hims & Hers Health shares in Q2 2022, an estimated $949K.
Ergoteles first reported a position in Hims & Hers Health in Q1 2022 and held it in 1 quarter.
Ergoteles's Hims & Hers Health position peaked at $949K in Q1 2022.
139 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2022.

Based on Ergoteles's 13F filing for Q2 2022, filed 12 Aug 2022.